Search

everythinglearnresearchcommunity

for

Search:↓

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

JAK inhibitors show promise for treating skin diseases effectively and safely.

A man developed a serious muscle breakdown condition after using a hair loss medication not known to cause this side effect.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Cromakalim relaxes various blood vessels, while minoxidil sulphate is more selective; they likely act on different potassium channels.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

The KAP 7 gene affects wool traits in Rambouillet sheep, with the BB genotype showing the best wool characteristics.

Ayurvedic treatment improved hair fall and scalp health.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

The serum is safe and effective for treating hair loss.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Combining Ayurvedic and modern treatments can effectively manage hair loss.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Axitinib treatment turned a man's grey hair back to black.

An integrated treatment approach effectively managed plaque psoriasis, leading to complete symptom resolution and hair regrowth.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Topical 5% minoxidil is safe and effective for treating hair loss in Korean men.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.